Computational study of some cancer drugs as potent inhibitors of GSK3β
A series of known Food and Drug Administration (FDA) approved anticancer drugs were collected from the literature and docked against Glycogen synthase kinase 3β (GSKβ) receptor which has been identified in present time as a target for therapeutic anticancer agents. The compounds binding affinities (...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-11-01
|
| Series: | Scientific African |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227620303495 |